Global Peptide CDMO Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 103

Published Date: 30 Jun 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Peptide CDMO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Peptide CDMO size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Peptide CDMO market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Peptide CDMO market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    LPPS
    SPPS
    Mixed Phase

Market segment by Application, can be divided into
    Pharmaceutical Industry
    Cosmetics Industry
    Others

Market segment by players, this report covers
    Thermo Fisher Pharma
    PolyPeptide
    Bachem
    ScinoPharm
    CBL
    AmbioPharm
    Piramal Pharma
    CordenPharma
    CPC SCIENTIFIC
    Provepharm
    Space Peptides
    Biopeptek
    Alpha Biophama
    Alabiochem
    Aurigene Pharmaceutical Services
    Chengdu Shengnuo Biotechnology Co., Ltd
    Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Peptide CDMO product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Peptide CDMO, with revenue, gross margin and global market share of Peptide CDMO from 2019 to 2021.
Chapter 3, the Peptide CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Peptide CDMO market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Peptide CDMO research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Peptide CDMO
    1.2 Classification of Peptide CDMO by Type
        1.2.1 Overview: Global Peptide CDMO Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Peptide CDMO Revenue Market Share by Type in 2020
        1.2.3 LPPS
        1.2.4 SPPS
        1.2.5 Mixed Phase
    1.3 Global Peptide CDMO Market by Application
        1.3.1 Overview: Global Peptide CDMO Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Pharmaceutical Industry
        1.3.3 Cosmetics Industry
        1.3.4 Others
    1.4 Global Peptide CDMO Market Size & Forecast
    1.5 Global Peptide CDMO Market Size and Forecast by Region
        1.5.1 Global Peptide CDMO Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Peptide CDMO Market Size by Region, (2016-2021)
        1.5.3 North America Peptide CDMO Market Size and Prospect (2016-2026)
        1.5.4 Europe Peptide CDMO Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Peptide CDMO Market Size and Prospect (2016-2026)
        1.5.6 South America Peptide CDMO Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Peptide CDMO Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Peptide CDMO Market Drivers
        1.6.2 Peptide CDMO Market Restraints
        1.6.3 Peptide CDMO Trends Analysis

2 Company Profiles
    2.1 Thermo Fisher Pharma
        2.1.1 Thermo Fisher Pharma Details
        2.1.2 Thermo Fisher Pharma Major Business
        2.1.3 Thermo Fisher Pharma Peptide CDMO Product and Solutions
        2.1.4 Thermo Fisher Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Thermo Fisher Pharma Recent Developments and Future Plans
    2.2 PolyPeptide
        2.2.1 PolyPeptide Details
        2.2.2 PolyPeptide Major Business
        2.2.3 PolyPeptide Peptide CDMO Product and Solutions
        2.2.4 PolyPeptide Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 PolyPeptide Recent Developments and Future Plans
    2.3 Bachem
        2.3.1 Bachem Details
        2.3.2 Bachem Major Business
        2.3.3 Bachem Peptide CDMO Product and Solutions
        2.3.4 Bachem Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Bachem Recent Developments and Future Plans
    2.4 ScinoPharm
        2.4.1 ScinoPharm Details
        2.4.2 ScinoPharm Major Business
        2.4.3 ScinoPharm Peptide CDMO Product and Solutions
        2.4.4 ScinoPharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 ScinoPharm Recent Developments and Future Plans
    2.5 CBL
        2.5.1 CBL Details
        2.5.2 CBL Major Business
        2.5.3 CBL Peptide CDMO Product and Solutions
        2.5.4 CBL Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 CBL Recent Developments and Future Plans
    2.6 AmbioPharm
        2.6.1 AmbioPharm Details
        2.6.2 AmbioPharm Major Business
        2.6.3 AmbioPharm Peptide CDMO Product and Solutions
        2.6.4 AmbioPharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 AmbioPharm Recent Developments and Future Plans
    2.7 Piramal Pharma
        2.7.1 Piramal Pharma Details
        2.7.2 Piramal Pharma Major Business
        2.7.3 Piramal Pharma Peptide CDMO Product and Solutions
        2.7.4 Piramal Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Piramal Pharma Recent Developments and Future Plans
    2.8 CordenPharma
        2.8.1 CordenPharma Details
        2.8.2 CordenPharma Major Business
        2.8.3 CordenPharma Peptide CDMO Product and Solutions
        2.8.4 CordenPharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 CordenPharma Recent Developments and Future Plans
    2.9 CPC SCIENTIFIC
        2.9.1 CPC SCIENTIFIC Details
        2.9.2 CPC SCIENTIFIC Major Business
        2.9.3 CPC SCIENTIFIC Peptide CDMO Product and Solutions
        2.9.4 CPC SCIENTIFIC Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 CPC SCIENTIFIC Recent Developments and Future Plans
    2.10 Provepharm
        2.10.1 Provepharm Details
        2.10.2 Provepharm Major Business
        2.10.3 Provepharm Peptide CDMO Product and Solutions
        2.10.4 Provepharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Provepharm Recent Developments and Future Plans
    2.11 Space Peptides
        2.11.1 Space Peptides Details
        2.11.2 Space Peptides Major Business
        2.11.3 Space Peptides Peptide CDMO Product and Solutions
        2.11.4 Space Peptides Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Space Peptides Recent Developments and Future Plans
    2.12 Biopeptek
        2.12.1 Biopeptek Details
        2.12.2 Biopeptek Major Business
        2.12.3 Biopeptek Peptide CDMO Product and Solutions
        2.12.4 Biopeptek Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Biopeptek Recent Developments and Future Plans
    2.13 Alpha Biophama
        2.13.1 Alpha Biophama Details
        2.13.2 Alpha Biophama Major Business
        2.13.3 Alpha Biophama Peptide CDMO Product and Solutions
        2.13.4 Alpha Biophama Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Alpha Biophama Recent Developments and Future Plans
    2.14 Alabiochem
        2.14.1 Alabiochem Details
        2.14.2 Alabiochem Major Business
        2.14.3 Alabiochem Peptide CDMO Product and Solutions
        2.14.4 Alabiochem Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Alabiochem Recent Developments and Future Plans
    2.15 Aurigene Pharmaceutical Services
        2.15.1 Aurigene Pharmaceutical Services Details
        2.15.2 Aurigene Pharmaceutical Services Major Business
        2.15.3 Aurigene Pharmaceutical Services Peptide CDMO Product and Solutions
        2.15.4 Aurigene Pharmaceutical Services Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Aurigene Pharmaceutical Services Recent Developments and Future Plans
    2.16 Chengdu Shengnuo Biotechnology Co., Ltd
        2.16.1 Chengdu Shengnuo Biotechnology Co., Ltd Details
        2.16.2 Chengdu Shengnuo Biotechnology Co., Ltd Major Business
        2.16.3 Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Product and Solutions
        2.16.4 Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 Chengdu Shengnuo Biotechnology Co., Ltd Recent Developments and Future Plans
    2.17 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd
        2.17.1 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Details
        2.17.2 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Major Business
        2.17.3 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Product and Solutions
        2.17.4 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Peptide CDMO Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Peptide CDMO Players Market Share
        3.2.2 Top 10 Peptide CDMO Players Market Share
        3.2.3 Market Competition Trend
    3.3 Peptide CDMO Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Peptide CDMO Revenue and Market Share by Type (2016-2021)
    4.2 Global Peptide CDMO Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Peptide CDMO Revenue Market Share by Application (2016-2021)
    5.2 Peptide CDMO Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Peptide CDMO Revenue by Type (2016-2026)
    6.2 North America Peptide CDMO Revenue by Application (2016-2026)
    6.3 North America Peptide CDMO Market Size by Country
        6.3.1 North America Peptide CDMO Revenue by Country (2016-2026)
        6.3.2 United States Peptide CDMO Market Size and Forecast (2016-2026)
        6.3.3 Canada Peptide CDMO Market Size and Forecast (2016-2026)
        6.3.4 Mexico Peptide CDMO Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Peptide CDMO Revenue by Type (2016-2026)
    7.2 Europe Peptide CDMO Revenue by Application (2016-2026)
    7.3 Europe Peptide CDMO Market Size by Country
        7.3.1 Europe Peptide CDMO Revenue by Country (2016-2026)
        7.3.2 Germany Peptide CDMO Market Size and Forecast (2016-2026)
        7.3.3 France Peptide CDMO Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Peptide CDMO Market Size and Forecast (2016-2026)
        7.3.5 Russia Peptide CDMO Market Size and Forecast (2016-2026)
        7.3.6 Italy Peptide CDMO Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Peptide CDMO Revenue by Type (2016-2026)
    8.2 Asia-Pacific Peptide CDMO Revenue by Application (2016-2026)
    8.3 Asia-Pacific Peptide CDMO Market Size by Region
        8.3.1 Asia-Pacific Peptide CDMO Revenue by Region (2016-2026)
        8.3.2 China Peptide CDMO Market Size and Forecast (2016-2026)
        8.3.3 Japan Peptide CDMO Market Size and Forecast (2016-2026)
        8.3.4 South Korea Peptide CDMO Market Size and Forecast (2016-2026)
        8.3.5 India Peptide CDMO Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Peptide CDMO Market Size and Forecast (2016-2026)
        8.3.7 Australia Peptide CDMO Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Peptide CDMO Revenue by Type (2016-2026)
    9.2 South America Peptide CDMO Revenue by Application (2016-2026)
    9.3 South America Peptide CDMO Market Size by Country
        9.3.1 South America Peptide CDMO Revenue by Country (2016-2026)
        9.3.2 Brazil Peptide CDMO Market Size and Forecast (2016-2026)
        9.3.3 Argentina Peptide CDMO Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Peptide CDMO Revenue by Type (2016-2026)
    10.2 Middle East & Africa Peptide CDMO Revenue by Application (2016-2026)
    10.3 Middle East & Africa Peptide CDMO Market Size by Country
        10.3.1 Middle East & Africa Peptide CDMO Revenue by Country (2016-2026)
        10.3.2 Turkey Peptide CDMO Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Peptide CDMO Market Size and Forecast (2016-2026)
        10.3.4 UAE Peptide CDMO Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Peptide CDMO Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Peptide CDMO Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Peptide CDMO Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Peptide CDMO Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Peptide CDMO Revenue Market Share by Region (2021-2026)
    Table 6. Thermo Fisher Pharma Corporate Information, Head Office, and Major Competitors
    Table 7. Thermo Fisher Pharma Major Business
    Table 8. Thermo Fisher Pharma Peptide CDMO Product and Solutions
    Table 9. Thermo Fisher Pharma Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. PolyPeptide Corporate Information, Head Office, and Major Competitors
    Table 11. PolyPeptide Major Business
    Table 12. PolyPeptide Peptide CDMO Product and Solutions
    Table 13. PolyPeptide Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Bachem Corporate Information, Head Office, and Major Competitors
    Table 15. Bachem Major Business
    Table 16. Bachem Peptide CDMO Product and Solutions
    Table 17. Bachem Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. ScinoPharm Corporate Information, Head Office, and Major Competitors
    Table 19. ScinoPharm Major Business
    Table 20. ScinoPharm Peptide CDMO Product and Solutions
    Table 21. ScinoPharm Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. CBL Corporate Information, Head Office, and Major Competitors
    Table 23. CBL Major Business
    Table 24. CBL Peptide CDMO Product and Solutions
    Table 25. CBL Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. AmbioPharm Corporate Information, Head Office, and Major Competitors
    Table 27. AmbioPharm Major Business
    Table 28. AmbioPharm Peptide CDMO Product and Solutions
    Table 29. AmbioPharm Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Piramal Pharma Corporate Information, Head Office, and Major Competitors
    Table 31. Piramal Pharma Major Business
    Table 32. Piramal Pharma Peptide CDMO Product and Solutions
    Table 33. Piramal Pharma Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. CordenPharma Corporate Information, Head Office, and Major Competitors
    Table 35. CordenPharma Major Business
    Table 36. CordenPharma Peptide CDMO Product and Solutions
    Table 37. CordenPharma Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. CPC SCIENTIFIC Corporate Information, Head Office, and Major Competitors
    Table 39. CPC SCIENTIFIC Major Business
    Table 40. CPC SCIENTIFIC Peptide CDMO Product and Solutions
    Table 41. CPC SCIENTIFIC Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Provepharm Corporate Information, Head Office, and Major Competitors
    Table 43. Provepharm Major Business
    Table 44. Provepharm Peptide CDMO Product and Solutions
    Table 45. Provepharm Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Space Peptides Corporate Information, Head Office, and Major Competitors
    Table 47. Space Peptides Major Business
    Table 48. Space Peptides Peptide CDMO Product and Solutions
    Table 49. Space Peptides Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Biopeptek Corporate Information, Head Office, and Major Competitors
    Table 51. Biopeptek Major Business
    Table 52. Biopeptek Peptide CDMO Product and Solutions
    Table 53. Biopeptek Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Alpha Biophama Corporate Information, Head Office, and Major Competitors
    Table 55. Alpha Biophama Major Business
    Table 56. Alpha Biophama Peptide CDMO Product and Solutions
    Table 57. Alpha Biophama Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Alabiochem Corporate Information, Head Office, and Major Competitors
    Table 59. Alabiochem Major Business
    Table 60. Alabiochem Peptide CDMO Product and Solutions
    Table 61. Alabiochem Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Aurigene Pharmaceutical Services Corporate Information, Head Office, and Major Competitors
    Table 63. Aurigene Pharmaceutical Services Major Business
    Table 64. Aurigene Pharmaceutical Services Peptide CDMO Product and Solutions
    Table 65. Aurigene Pharmaceutical Services Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 66. Chengdu Shengnuo Biotechnology Co., Ltd Corporate Information, Head Office, and Major Competitors
    Table 67. Chengdu Shengnuo Biotechnology Co., Ltd Major Business
    Table 68. Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Product and Solutions
    Table 69. Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 70. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Corporate Information, Head Office, and Major Competitors
    Table 71. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Major Business
    Table 72. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Product and Solutions
    Table 73. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 74. Global Peptide CDMO Revenue (USD Million) by Players (2019-2021)
    Table 75. Global Peptide CDMO Revenue Share by Players (2019-2021)
    Table 76. Breakdown of Peptide CDMO by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 77. Peptide CDMO Players Head Office, Products and Services Provided
    Table 78. Peptide CDMO Mergers & Acquisitions in the Past Five Years
    Table 79. Peptide CDMO New Entrants and Expansion Plans
    Table 80. Global Peptide CDMO Revenue (USD Million) by Type (2016-2021)
    Table 81. Global Peptide CDMO Revenue Share by Type (2016-2021)
    Table 82. Global Peptide CDMO Revenue Forecast by Type (2021-2026)
    Table 83. Global Peptide CDMO Revenue by Application (2016-2021)
    Table 84. Global Peptide CDMO Revenue Forecast by Application (2021-2026)
    Table 85. North America Peptide CDMO Revenue by Type (2016-2021) & (USD Million)
    Table 86. North America Peptide CDMO Revenue by Type (2021-2026) & (USD Million)
    Table 87. North America Peptide CDMO Revenue by Application (2016-2021) & (USD Million)
    Table 88. North America Peptide CDMO Revenue by Application (2021-2026) & (USD Million)
    Table 89. North America Peptide CDMO Revenue by Country (2016-2021) & (USD Million)
    Table 90. North America Peptide CDMO Revenue by Country (2021-2026) & (USD Million)
    Table 91. Europe Peptide CDMO Revenue by Type (2016-2021) & (USD Million)
    Table 92. Europe Peptide CDMO Revenue by Type (2021-2026) & (USD Million)
    Table 93. Europe Peptide CDMO Revenue by Application (2016-2021) & (USD Million)
    Table 94. Europe Peptide CDMO Revenue by Application (2021-2026) & (USD Million)
    Table 95. Europe Peptide CDMO Revenue by Country (2016-2021) & (USD Million)
    Table 96. Europe Peptide CDMO Revenue by Country (2021-2026) & (USD Million)
    Table 97. Asia-Pacific Peptide CDMO Revenue by Type (2016-2021) & (USD Million)
    Table 98. Asia-Pacific Peptide CDMO Revenue by Type (2021-2026) & (USD Million)
    Table 99. Asia-Pacific Peptide CDMO Revenue by Application (2016-2021) & (USD Million)
    Table 100. Asia-Pacific Peptide CDMO Revenue by Application (2021-2026) & (USD Million)
    Table 101. Asia-Pacific Peptide CDMO Revenue by Region (2016-2021) & (USD Million)
    Table 102. Asia-Pacific Peptide CDMO Revenue by Region (2021-2026) & (USD Million)
    Table 103. South America Peptide CDMO Revenue by Type (2016-2021) & (USD Million)
    Table 104. South America Peptide CDMO Revenue by Type (2021-2026) & (USD Million)
    Table 105. South America Peptide CDMO Revenue by Application (2016-2021) & (USD Million)
    Table 106. South America Peptide CDMO Revenue by Application (2021-2026) & (USD Million)
    Table 107. South America Peptide CDMO Revenue by Country (2016-2021) & (USD Million)
    Table 108. South America Peptide CDMO Revenue by Country (2021-2026) & (USD Million)
    Table 109. Middle East & Africa Peptide CDMO Revenue by Type (2016-2021) & (USD Million)
    Table 110. Middle East & Africa Peptide CDMO Revenue by Type (2021-2026) & (USD Million)
    Table 111. Middle East & Africa Peptide CDMO Revenue by Application (2016-2021) & (USD Million)
    Table 112. Middle East & Africa Peptide CDMO Revenue by Application (2021-2026) & (USD Million)
    Table 113. Middle East & Africa Peptide CDMO Revenue by Country (2016-2021) & (USD Million)
    Table 114. Middle East & Africa Peptide CDMO Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Peptide CDMO Picture
    Figure 2. Global Peptide CDMO Revenue Market Share by Type in 2020
    Figure 3. LPPS
    Figure 4. SPPS
    Figure 5. Mixed Phase
    Figure 6. Peptide CDMO Revenue Market Share by Application in 2020
    Figure 7. Pharmaceutical Industry Picture
    Figure 8. Cosmetics Industry Picture
    Figure 9. Others Picture
    Figure 10. Global Peptide CDMO Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 11. Global Peptide CDMO Revenue and Forecast (2016-2026) & (USD Million)
    Figure 12. Global Peptide CDMO Revenue Market Share by Region (2016-2026)
    Figure 13. Global Peptide CDMO Revenue Market Share by Region in 2020
    Figure 14. North America Peptide CDMO Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Europe Peptide CDMO Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. Asia-Pacific Peptide CDMO Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. South America Peptide CDMO Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Middle East and Africa Peptide CDMO Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Peptide CDMO Market Drivers
    Figure 20. Peptide CDMO Market Restraints
    Figure 21. Peptide CDMO Market Trends
    Figure 22. Thermo Fisher Pharma Recent Developments and Future Plans
    Figure 23. PolyPeptide Recent Developments and Future Plans
    Figure 24. Bachem Recent Developments and Future Plans
    Figure 25. ScinoPharm Recent Developments and Future Plans
    Figure 26. CBL Recent Developments and Future Plans
    Figure 27. AmbioPharm Recent Developments and Future Plans
    Figure 28. Piramal Pharma Recent Developments and Future Plans
    Figure 29. CordenPharma Recent Developments and Future Plans
    Figure 30. CPC SCIENTIFIC Recent Developments and Future Plans
    Figure 31. Provepharm Recent Developments and Future Plans
    Figure 32. Space Peptides Recent Developments and Future Plans
    Figure 33. Biopeptek Recent Developments and Future Plans
    Figure 34. Alpha Biophama Recent Developments and Future Plans
    Figure 35. Alabiochem Recent Developments and Future Plans
    Figure 36. Aurigene Pharmaceutical Services Recent Developments and Future Plans
    Figure 37. Chengdu Shengnuo Biotechnology Co., Ltd Recent Developments and Future Plans
    Figure 38. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Recent Developments and Future Plans
    Figure 39. Global Peptide CDMO Revenue Share by Players in 2020
    Figure 40. Peptide CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 41. Global Top 3 Players Peptide CDMO Revenue Market Share in 2020
    Figure 42. Global Top 10 Players Peptide CDMO Revenue Market Share in 2020
    Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 44. Global Peptide CDMO Revenue Share by Type in 2020
    Figure 45. Global Peptide CDMO Market Share Forecast by Type (2021-2026)
    Figure 46. Global Peptide CDMO Revenue Share by Application in 2020
    Figure 47. Global Peptide CDMO Market Share Forecast by Application (2021-2026)
    Figure 48. North America Peptide CDMO Sales Market Share by Type (2016-2026)
    Figure 49. North America Peptide CDMO Sales Market Share by Application (2016-2026)
    Figure 50. North America Peptide CDMO Revenue Market Share by Country (2016-2026)
    Figure 51. United States Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Canada Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Mexico Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Europe Peptide CDMO Sales Market Share by Type (2016-2026)
    Figure 55. Europe Peptide CDMO Sales Market Share by Application (2016-2026)
    Figure 56. Europe Peptide CDMO Revenue Market Share by Country (2016-2026)
    Figure 57. Germany Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. France Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. United Kingdom Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Russia Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Italy Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Asia-Pacific Peptide CDMO Sales Market Share by Type (2016-2026)
    Figure 63. Asia-Pacific Peptide CDMO Sales Market Share by Application (2016-2026)
    Figure 64. Asia-Pacific Peptide CDMO Revenue Market Share by Region (2016-2026)
    Figure 65. China Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Japan Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. South Korea Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. India Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Southeast Asia Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Australia Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. South America Peptide CDMO Sales Market Share by Type (2016-2026)
    Figure 72. South America Peptide CDMO Sales Market Share by Application (2016-2026)
    Figure 73. South America Peptide CDMO Revenue Market Share by Country (2016-2026)
    Figure 74. Brazil Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Argentina Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Middle East and Africa Peptide CDMO Sales Market Share by Type (2016-2026)
    Figure 77. Middle East and Africa Peptide CDMO Sales Market Share by Application (2016-2026)
    Figure 78. Middle East and Africa Peptide CDMO Revenue Market Share by Country (2016-2026)
    Figure 79. Turkey Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. Saudi Arabia Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 81. UAE Peptide CDMO Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Thermo Fisher Pharma
PolyPeptide
Bachem
ScinoPharm
CBL
AmbioPharm
Piramal Pharma
CordenPharma
CPC SCIENTIFIC
Provepharm
Space Peptides
Biopeptek
Alpha Biophama
Alabiochem
Aurigene Pharmaceutical Services
Chengdu Shengnuo Biotechnology Co., Ltd
Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd

Related Reports

Global Peptide CDMO Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Peptide CDMO Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 17 Jan 2022

date Medical Care

The Peptide CDMO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Peptide CDMO Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Peptide CDMO Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 03 Mar 2022

date Pharma & Healthcare

Global Peptide CDMO Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Peptide CDMO Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.

Global Peptide CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Peptide CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 26 Apr 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Peptide CDMO market size was valued at USD 3265.7 million in 2022 and is forecast to a readjusted size of USD 8327.1 million by 2029 with a CAGR of 14.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Peptide CDMO Supply, Demand and Key Producers, 2023-2029

Global Peptide CDMO Supply, Demand and Key Producers, 2023-2029

date 26 Apr 2023

date Pharma & Healthcare

The global Peptide CDMO market size is expected to reach $ 8327.1 million by 2029, rising at a market growth of 14.3% CAGR during the forecast period (2023-2029).

Global Peptide CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Peptide CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Peptide CDMO market size was valued at USD 3265.7 million in 2023 and is forecast to a readjusted size of USD 8327.1 million by 2030 with a CAGR of 14.3% during review period.

Product Tags

peptide cdmo

Peptide CDMO Pharmaceutical

Peptide CDMO Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>